The Emotion Regulation of Acupuncture in Chronic Low Back Pain: A Clinical Neuroimaging Protocol
Peng Lai,Shirui Cheng,Xingyao Chen,Fangdong Cheng,Jun Cheng,Ming Xin,Deliang Zhu,Zhengjie Li,Xi Wu,Fang Zeng
DOI: https://doi.org/10.2147/jpr.s450589
IF: 2.8319
2024-03-02
Journal of Pain Research
Abstract:Peng Lai, 1, 2 Shirui Cheng, 1, 2 Xingyao Chen, 1 Fangdong Cheng, 3– 5 Jun Cheng, 3– 5 Ming Xin, 3, 4, 6 Deliang Zhu, 3, 4, 6 Zhengjie Li, 1, 2 Xi Wu, 1 Fang Zeng 1, 2 1 Acupuncture and Tuina School, Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, People's Republic of China; 2 Acupuncture & Brain Research Center, Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, People's Republic of China; 3 Geriatric Diseases Institute of Chengdu, Chengdu Fifth People's Hospital (The Second Clinical Medical College, Affiliated Fifth People's Hospital of Chengdu University of Traditional Chinese Medicine), Chengdu, Sichuan, People's Republic of China; 4 Cancer Prevention and Treatment Institute of Chengdu, Chengdu Fifth People's Hospital (The Second Clinical Medical College, Affiliated Fifth People's Hospital of Chengdu University of Traditional Chinese Medicine), Chengdu, Sichuan, People's Republic of China; 5 Department of Orthopedic, Chengdu Fifth People's Hospital (The Second Clinical Medical College, Affiliated Fifth People's Hospital of Chengdu University of Traditional Chinese Medicine), Chengdu, Sichuan, People's Republic of China; 6 Department of Rehabilitation, Chengdu Fifth People's Hospital (The Second Clinical Medical College, Affiliated Fifth People's Hospital of Chengdu University of Traditional Chinese Medicine), Chengdu, Sichuan, People's Republic of China Correspondence: Fang Zeng; Xi Wu, Email ; Introduction: Acupuncture is effective for patients with chronic low back pain (CLBP), which can relieve pain intensity and regulate negative emotional states such as pain-related anxiety and depression. Previous studies mainly discuss the analgesic mechanism of acupuncture treatment of CLBP, but there are multiple dimensions to pain, including sensation, emotion and cognition. Therefore, this study aims to investigate the central mechanism of acupuncture for CLBP from the perspective of emotional regulation by functional magnetic resonance imaging (fMRI). Methods and Analysis: A total of 72 patients with CLBP will be recruited in the study and randomly assigned to the verum acupuncture group or the sham acupuncture group. The trail will last for 18 weeks including a 2-week baseline, a 4-week treatment and a 12-week for follow-up period. The primary outcomes are the visual analog scale (VAS) and the Japanese Orthopaedic Association Scores (JOA) score. The secondary outcomes are the 12-item short form health survey (SF-12), the state trait anxiety inventory (STAI), the self-rating anxiety scale (SAS) and self-rating depression scale (SDS). The VAS, JOA, STAI SAS and SDS will be collected at baseline, week 2, week 4, and after follow-up. The SF-12 will be evaluated at baseline, week 2 and week 4. Functional magnetic resonance imaging (MRI) data will be collected at baseline and the end of treatment. Emotion-related brain regions will be chosen as regions of interest (ROIs). The gray matter volume (GMV), amplitude of low-frequency fluctuation (ALFF), regional homogeneity (ReHo), functional connectivity (FC), and large-scale functional brain network based on these ROIs will be analyzed within and between the two groups. Discussion: This study will verify the emotional regulation of acupuncture and explore the mechanism of acupuncture for emotion regulation in patients with CLBP. Trial Registration Number: https://www.chictr.org.cn/showproj.html?proj=195486 , identifier: ChiCTR2300070557. Keywords: acupuncture, chronic low back pain, emotion regulation, functional magnetic resonance imaging Chronic low back pain (CLBP) mainly refers to long-term pain that lasts for more than three months, usually accompanied by discomfort, tightness, or stiffness in the area below the ribs and above the buttocks. 1,2 CLBP is second only to lung cancer and ischemic heart disease in terms of disability-adjusted life years, 3 which impacts approximately 10–13% of the adult population, accounting for over 30 million people in the United States. 4 It is a major health problem with significant economic and social implications, accounting for more than 80% of healthcare expenditure, 5 with an average annual expenditure $34 billion. 6 According to the clinical practice guideline of the American College of Physicians (ACP), current pharmacotherapies for CLBP include non-steroidal anti-inflammatory drugs (NSAIDs), opioid analgesics, nonopioid analgesics, tramadol, antidepressants, benzodiazepines, corticosteroids, antiepile -Abstract Truncated-
clinical neurology